
“Looking for the very highest quality products and the consistency of a high-tech pharmaceuticals operation? Vida expects to file its licensing application before the end of April, a schedule that should allow it to have the necessary license in hand by the third quarter of this year. In the meantime, the company is raising $1.5 million at $.25 per share. That represents a market value of only $6 million for a company that now owns a 315,000-square-foot production plant with a replacement value estimated at $30 million. Personally, I think this will turn out to be an extraordinary investment. In less than a year’s time, this $.25 financing round is going to look extremely cheap.”
Related posts:
Surprise, Surprise Again
All-Time High Unemployment: Depression In Europe Getting Deeper
Trump Betrays Trumpism: Syria in the Crosshairs
Ron Paul on Iran Protests...CIA Fingerprints?
Judge blasts FBI for bugging courthouse, throws out 200 hours of recordings
Tuur Demeester: Why You Should Invest in Bicoin
Glenn Greenwald slams Rep. Peter King: He supported terrorism for decades
The Dutch do what the Germans couldn't: Get their gold back
Making Rent With Bitcoins and Rentalutions
State Gasoline Tax Rates 2013
Cities’ Strategy in Health Insurance for Retirees: “Dump Them Into ObamaCare!”
CNET Founder Creates New Venture That Addresses Bitcoin Volatility
A Year Later, A Veteran Still Sits In Jail, Denied Bail For Leaking Now-Public Docs
In Jefferson County, Drug Cops Run Wild
Occupy debt-relief campaign buys, forgives $100,000 worth of debt